Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?
JAMA · 02.07.2024 · 332 (1) · 9
DOI: 10.1001/jama.2024.6586 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 02.07.2024. Verfasst von Caterina Conte und 2 weiteren Autor:innen. Beteiligte Einrichtung: San Raffaele Roma Open University, Rome, Italy, and IRCCS MultiMedica, Milan, Italy. Hauptthemen laut MEDLINE: Muscle, Skeletal, Obesity, Weight Loss, Sarcopenia. Die Arbeit wurde bisher 193-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
This Viewpoint explores the effects of weight loss achieved through GLP-1–based antiobesity medications on weight regain, fat-free mass, and skeletal muscle mass in people with obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- San Raffaele Roma Open University, Rome, Italy, and IRCCS MultiMedica, Milan, Italy.
- National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
- Washington University School of Medicine in St Louis, St Louis, Missouri.
Zitieren
APA
Conte, C., Hall, K. D., & Klein, S. (2024). Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?. JAMA, 332(1), 9. https://doi.org/10.1001/jama.2024.6586
Vancouver
Conte C, Hall KD, Klein S. Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?. JAMA. 2024;332(1):9. doi:10.1001/jama.2024.6586
BibTeX
@article{Conte2024,
author = {Conte, Caterina and Hall, Kevin D and Klein, Samuel},
title = {Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?},
journal = {JAMA},
year = {2024},
volume = {332},
number = {1},
pages = {9},
doi = {10.1001/jama.2024.6586}
}
EUVIMED